Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Quest Diagnostics Incorporated DGX

Healthcare  —  Diagnostics & Research
236.32 (0.27) (0.11%) as of 25 Sep
Market cap
$26.2B
P/E
24.8×
S&P 500 Member Dividend Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue 7,214.00 7,402.00 7,531.00 7,726.00 9,437.00 10,788.00 9,883.00 9,252.00 9,872.00 11,035.00
Revenue Growth (3.72%) 2.61% 1.74% 2.59% 22.15% 14.32% (8.39%) (6.38%) 6.70% 11.78%
Cost of Revenue 4,616.00 4,719.00 4,926.00 5,037.00 5,804.00 6,579.00 6,450.00 6,199.00 6,628.00 7,370.00
Gross Profit 2,598.00 2,683.00 2,605.00 2,689.00 3,633.00 4,209.00 3,433.00 3,053.00 3,244.00 3,665.00
SG&A Expenses 1,380.00 1,443.00 1,424.00 1,457.00 1,550.00 1,727.00 1,874.00 1,642.00 1,770.00 1,967.00
Operating Income 1,277.00 1,165.00 1,101.00 1,231.00 1,971.00 2,381.00 1,428.00 1,262.00 1,346.00 1,556.00
Non-operating Income/Expense (191.00) (135.00) (175.00) (155.00) (87.00) 218.00 (193.00) (132.00) (171.00) (238.00)
Non-operating Interest Expenses 143.00 151.00 167.00 175.00 163.00 151.00 138.00 152.00 201.00 264.00
EBT 1,086.00 1,030.00 926.00 1,076.00 1,884.00 2,599.00 1,235.00 1,130.00 1,175.00 1,318.00
Income Tax Provision 429.00 241.00 182.00 247.00 460.00 597.00 264.00 248.00 273.00 314.00
Income after Tax 657.00 789.00 744.00 829.00 1,424.00 2,002.00 971.00 882.00 902.00 1,004.00
Share of Subsidiary Earnings 39.00 35.00 44.00 57.00 75.00 78.00 44.00 26.00 19.00 42.00
Dividends (Preferred) 3.00 3.00 3.00 — 6.00 7.00 4.00 4.00 5.00 4.00
Non-Controlling Interest 51.00 52.00 52.00 48.00 68.00 85.00 69.00 54.00 50.00 54.00
Net Income Common 642.00 772.00 736.00 858.00 1,425.00 1,988.00 942.00 850.00 866.00 988.00
EPS (Basic) 4.58 5.63 5.39 6.36 10.62 15.85 8.10 7.59 7.78 8.87
EPS (Diluted) 4.51 5.50 5.29 6.28 10.47 15.55 7.97 7.49 7.69 8.75
Shares (Basic, Weighted) 140.00 137.00 136.00 134.00 134.00 125.00 116.00 112.00 111.00 111.00
Shares (Diluted, Weighted) 142.00 140.00 139.00 136.00 136.00 128.00 118.00 113.00 113.00 113.00
Gross Margin 36.01% 36.25% 34.59% 34.80% 38.50% 39.02% 34.74% 33.00% 32.86% 33.21%
EBIT Margin 17.70% 15.74% 14.62% 15.93% 20.89% 22.07% 14.45% 13.64% 13.63% 14.10%
EBT margin 15.05% 13.92% 12.30% 13.93% 19.96% 24.09% 12.50% 12.21% 11.90% 11.94%
Net Profit Margin 8.90% 10.43% 9.77% 11.11% 15.10% 18.43% 9.53% 9.19% 8.77% 8.95%
Free Cash Flow Margin 11.41% 12.47% 10.85% 10.91% 16.82% 16.96% 13.30% 9.34% 9.21% 12.32%
EBITDA 1,526.00 1,435.00 1,410.00 1,560.00 2,332.00 2,789.00 1,865.00 1,701.00 1,839.00 2,126.00
EBIT 1,277.00 1,165.00 1,101.00 1,231.00 1,971.00 2,381.00 1,428.00 1,262.00 1,346.00 1,556.00
Income from Continuous Operations 696.00 824.00 788.00 886.00 1,499.00 2,080.00 1,015.00 908.00 921.00 1,046.00
Income from Discontinued Operations — — — 20.00 — — — — — —
Consolidated Net Income/Loss 696.00 824.00 788.00 906.00 1,499.00 2,080.00 1,015.00 908.00 921.00 1,046.00
EPS (Basic, from Continuous Ops) 4.97 5.63 5.39 6.21 11.19 16.64 8.75 8.11 8.30 9.42
EPS (Basic, from Discontinued Ops) — — — 0.15 — — — — — —
EPS (Basic, Consolidated) 4.97 6.01 5.79 6.76 11.19 16.64 8.75 8.11 8.30 9.42
EPS (Diluted, from Cont. Ops) 4.90 5.50 5.29 6.13 11.02 16.25 8.60 8.04 8.15 9.26
EPS (Diluted, from Disc. Ops) — — — 0.00 — — — — — —
Shares (Diluted, Average) 142.00 140.00 139.00 136.00 136.00 128.00 118.00 113.00 113.00 113.00
EPS (Diluted, Consolidated) 4.90 5.89 5.67 6.66 11.02 16.25 8.60 8.04 8.15 9.26
EBITDA Margin 21.15% 19.39% 18.72% 20.19% 24.71% 25.85% 18.87% 18.39% 18.63% 19.27%
Operating Cash Flow Margin 15.47% 15.87% 15.93% 16.09% 21.25% 20.70% 17.38% 13.75% 13.51% 17.09%

Fold the line items

In millions of $ except per-share values · columns are period end dates